Hyperglycemia, tumorigenesis, and chronic inflammation.

Area of Science:

• Endocrinology and Metabolism
• Oncology
• Immunology

Background:

• Hyperglycemia, a hallmark of diabetes, provides energy for malignant cell proliferation.
• Elevated glucose metabolism in diabetics correlates with increased chronic inflammatory markers (e.g., IL-1β, IL-6, TNF-α).
• Immune system activation is increasingly recognized in cancer progression and development.

Purpose of the Study:

• To explore the intricate relationship between hyperglycemia, chronic inflammation, and tumorigenesis.
• To elucidate the molecular mechanisms linking hyperglycemia to immune overactivation and tumor microenvironment changes.
• To review the role of hyperglycemia in specific cancers and discuss future therapeutic strategies.

Main Methods:

• Literature review of hyperglycemia-associated diseases and cancer risk.
• Analysis of molecular mechanisms of glycosylation in proteoglycans under hyperglycemia.
• Discussion of hyperglycemia's contribution to tumorigenesis and chronic inflammation.

Main Results:

• Hyperglycemia creates a pro-tumorigenic environment by supplying energy to cancer cells.
• Uncontrolled inflammation driven by hyperglycemia can foster a tumor-supportive microenvironment.
• Evidence links hyperglycemia to increased risk and progression in prostate, liver, colorectal, and pancreatic cancers.

Conclusions:

• Hyperglycemia significantly contributes to cancer development and progression through metabolic and inflammatory pathways.
• Targeting hyperglycemia and associated inflammation presents a promising therapeutic avenue for cancer treatment.
• Further research into hyperglycemia's impact on tumor biology and immunology is crucial for novel treatment development.